Rafael publishes a summons to the general meeting of shareholders
The meeting will take place on October 15, 2026. Documents can be viewed on the Maya website.
See the latest news and media coverage for Rafa. We track all announcements, press releases, and industry mentions in real time, all in one place.
Israeli pharmaceutical manufacturer, marketer, and distributor
rafa.co.ilLast updated
In short: Rafa secured major U.S. defense and health contracts, raised funds, and appointed a new CEO.
The meeting will take place on October 15, 2026. Documents can be viewed on the Maya website.
It continues to manufacture medicines and implemented a new advanced packaging machine for tablets and capsules.
Amir Levin, the outgoing CEO, will serve as Vice Chairman of the company.
The cannabis is produced by Panaxia, supplied as oil in fixed concentrations, and will be supplied directly to the patient's home at a significant discount for Maccabi members.
The Israeli pharmaceutical company will supply the U.S. Defense Logistics Agency over five years, with potential purchases rising to $257 million.
FC Barcelona head coach Hansi Flick gave an update on Gavi’s injury and also addressed the number 9 ...
Private equity firm FIMI bought control of pharmaceuticals company Rafa Laboratories from the Sackler family in 2020. Pharmaceuticals company Rafa Laboratories completed its raise via...
Track Rafa and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Rafa and other trending companies.